[Th1/Th2 balance in acute lymphoblastic leukemia in children]

Włodzimierz Luczyński1, Anna Stasiak-Barmuta, Maryna Krawczuk-Rybak

  • 1Klinika Onkologii Dzieciecej, Samodzielny Publiczny Dzieciecy, Szpital Kliniczny Akademii Medycznej w Białymstoku. vlodek@amb.edu.pl

Przeglad Lekarski
|April 5, 2005
PubMed

Insights

Pediatric acute lymphoblastic leukemia (ALL) shows a Th1/Th2 imbalance, with increased Th1 and Th2 cells during treatment. Infections exacerbate Th1 responses in children with ALL.

Area of Science:

  • Immunology
  • Pediatric Oncology

Context:

  • T helper cell subpopulations (Th1, Th2) are crucial for immune regulation.
  • Acute lymphoblastic leukemia (ALL) in children is a significant hematologic malignancy.
  • Understanding immune profiles in ALL is vital for treatment and prognosis.

Purpose:

  • To evaluate the Th1/Th2 cytokine balance in pediatric ALL patients.
  • To assess immune changes at diagnosis, during remission induction, and in the presence of infections.

Summary:

  • Flow cytometry measured T lymphocytes producing IFN-gamma (Th1) and IL-4 (Th2).
  • Elevated Th1 and Th2 percentages were observed in pediatric ALL patients compared to controls.
  • Infections led to increased Th1 cells without altering Th2 levels.

Impact:

  • Findings suggest a Th1/Th2 imbalance with Th2 predominance in pediatric ALL.
  • This immune dysregulation may influence disease progression and infection susceptibility.
  • Results highlight the need for targeted immunomodulatory strategies in pediatric ALL.